文献速递肥胖与代谢综合征

酒精与脂肪性肝病对高血浆小而密LDL-C浓度的关联存在差异

Alcohol and Steatotic Liver Disease Exhibit Divergent Associations with High Plasma Small Dense LDL-C Concentration.
PubMed 文献 · J Clin Endocrinol Metab · 2026-06-19

本研究为横断面研究,纳入2024年4月至2025年3月在日本新潟健康筛查的55,745名参与者,按脂肪性肝病状态和自报酒精摄入量分组,直接测量sdLDL-C(高值定义为≥35 mg/dL)。结果显示高sdLDL-C粗患病率在SLD阳性且过量饮酒组最高(76.4%);校正常规空腹血脂后,SLD相关关联减弱而酒精相关关联仍稳健,提示酒精暴露在当代SLD分类中独立促进致动脉粥样硬化性sdLDL-C表型。

要点

  • 高sdLDL-C粗患病率在SLD阳性且过量饮酒组最高,达76.4%。
  • 校正LDL-C、HDL-C和TG后,SLD相关关联减弱,酒精相关关联仍稳健。
  • 酒精暴露对sdLDL-C的效应超出常规空腹血脂,或有助于MetALD/ALD风险分层。

核心结论

  • 在当代SLD分类中,酒精暴露对致动脉粥样硬化性sdLDL-C表型的贡献超出常规空腹血脂,可能对MetALD/ALD风险分层有参考价值。

研究设计与样本

  • 横断面研究,纳入2024年4月至2025年3月在日本新潟接受健康筛查的55,745名参与者。
  • 酒精摄入为自报(低、中、过量),按SLD状态和酒精摄入分组,直接测量sdLDL-C,高sdLDL-C定义为≥35 mg/dL。
  • 采用多变量线性回归(sdLDL-C)和逻辑回归(高sdLDL-C),模型1校正年龄、性别、BMI、吸烟、降脂药、降压药和糖尿病,模型2进一步校正LDL-C、HDL-C和TG。
  • 采用g-computation估算边际标准化患病率和标准化患病率差(PDs),bootstrap迭代2000次。

主要发现

  • 高sdLDL-C粗患病率受SLD和酒精摄入影响,在SLD阳性且过量饮酒组最高(76.4%)。
  • 模型2中SLD相关关联减弱,而酒精相关关联仍稳健。
  • 在每个酒精类别内,SLD阳性的PD低于SLD阴性。

关键数值与推荐

  • 高sdLDL-C定义为≥35 mg/dL。
  • 高sdLDL-C粗患病率最高组为SLD阳性且过量饮酒组,为76.4%。

临床怎么用

  • 在评估SLD患者心血管风险时,除常规空腹血脂外,可关注酒精暴露对sdLDL-C的影响。
  • 对MetALD/ALD人群进行风险分层时,可考虑sdLDL-C作为额外指标。

局限性

  • 横断面设计无法推断因果关系。
  • 酒精摄入为自报,可能存在回忆偏倚。
  • 研究人群为日本健康筛查参与者,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Within the metabolic dysfunction-associated steatotic liver disease (MASLD)/MASLD with increased alcohol intake (MetALD)/alcohol-associated liver disease (ALD) framework, cardiovascular risk varies by alcohol exposure. As small dense low-density lipoprotein cholesterol (sdLDL-C) is highly atherogenic, this study assessed the relative effects of steatotic liver disease (SLD) and alcohol consumption on sdLDL-C elevation and the effects of conventional fasting lipids [low-density lipoprotein cholesterol (LDL-C)/high-density lipoprotein cholesterol (HDL-C)/triglycerides (TGs)] on these associations. METHODS: This cross-sectional study enrolled 55,745 participants who underwent health screenings in Niigata, Japan between April 2024 and March 2025. Alcohol consumption was self-reported as low, moderate, or excessive. Participants were grouped by SLD status and alcohol consumption. sdLDL-C was directly measured, with high sdLDL-C defined as ≥35 mg/dL. Multivariable linear regression (sdLDL-C) and logistic regression (high sdLDL-C) analyses used two models: model 1 was adjusted for age, sex, body mass index, smoking, lipid-lowering medication, antihypertensive medication, and diabetes, and model 2 was further adjusted for LDL-C, HDL-C, and TGs. Marginal standardized prevalence and standardized prevalence differences (PDs) were estimated using g-computation with 2000 bootstrap iterations. RESULTS: The crude prevalence of high sdLDL-C was influenced by SLD and alcohol consumption, being highest in the SLD(+)/excessive alcohol consumption group (76.4%). In model 2, SLD-related associations were attenuated, whereas alcohol-related associations remained robust, as the PD was lower for SLD(+) than for SLD(-) within each alcohol category. CONCLUSION: Alcohol exposure contributes to an atherogenic sdLDL-C phenotype beyond conventional fasting lipids within contemporary SLD categories, indicating potential relevance for risk profiling in MetALD/ALD.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Matsubayashi Y, Kato K, Watanabe M, et al. Alcohol and Steatotic Liver Disease Exhibit Divergent Associations with High Plasma Small Dense LDL-C Concentration. J Clin Endocrinol Metab. 2026. PMID: 42319754. doi:10.1210/clinem/dgag234

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。